pathway (J Clin
Invest 2000, Nat Med 2004, EMBO Mol Med 2012, PLOS Genet 2017), the mTOR/AKT pathway (Nat Med 2013, NEJM 2014...), the Lcn2 pathway (J Clin
Invest 2010, Nat Commun 2016, Cell Report 2019, Cell Report 2023) and more recently the Hippo... -
Voir cette offre d'emploi